Or. Admin. R. 333-010-0032 - Cancer Reporting Regulations: Reporting Requirements for Clinical Laboratories

(1) Clinical laboratories must report to OSCaR all cases with test results indicative of and specific for a reportable cancer or reportable non-malignant condition, as defined in OAR 333-010-0000(16) and 333-010-0000(18) respectively, ("Cancer Pathology Reports") in accordance with the following provisions. Clinical laboratories must submit all Cancer Pathology Reports to OSCaR using the electronic data exchange format and codes set forth in the guidelines for Pathology Laboratory Electronic Reporting issued by the North American Association of Central Cancer Registries ("NAACCR"), unless reported to a health system cancer registry. The NAACCR Guidelines for Pathology Laboratory Electronic Reporting are available from OSCaR.
(2) Clinical laboratories must also report to OSCaR all cases with biopsies (excluding cytologic tests) indicative of and specific for a reportable pre-malignant condition, as defined in OAR 333-010-0000(16), in an electronic format directed by OSCaR. These reports must include (if available to the clinical laboratory):
(a) Name, address, and telephone number of the physician listed on the lab order;
(b) Name, address, and telephone number of the reporting laboratory;
(c) Patient name, gender, address (if available), birth date, race/ethnicity;
(d) Primary site and type of cancer-related condition; and
(e) Date of diagnosis.
(3) OSCaR will make lists of reportable cancers, reportable non-malignant conditions, and reportable pre-malignant conditions available on the Oregon State Cancer Registry website: www.healthoregon.org/oscar. If a clinical laboratory fails to submit the required cancer pathology reports or reports of pre-malignant conditions to OSCaR according to the standards and format prescribed, OSCaR may inform the laboratory in writing of the disparity between the laboratory's reporting performance and the reporting standards and consult with the laboratory regarding methods for bringing the clinical laboratory's reporting performance into compliance with the reporting standards.
(4) If a clinical laboratory is not able to submit cancer pathology reports or reports of pre-malignant conditions electronically, OSCaR may authorize the clinical laboratory to report by mail or facsimile for a limited period of time to be specified by OSCaR.
(5) OSCaR shall establish a system of confirmation of receipt of cancer pathology reports and reports of pre-malignant conditions submitted by clinical laboratories.

Notes

Or. Admin. R. 333-010-0032
PH 13-2011, f. 12-28-11, cert. ef. 1-1-12; PH 20-2017, amend filed 12/21/2017, effective 1/1/2018

Statutory/Other Authority: ORS 432.510 & 432.520

Statutes/Other Implemented: ORS 432.510 & 432.520

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.


No prior version found.